Andrew H. Wei

OncoDaily

News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary

Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me

April, 2025

Andrew H. Wei

Dec 23, 2024, 11:55 | Drugs

Talha Badar: Venetoclax and Azacitidine for elderly AML ineligible for intensive Induction

Talha Badar shared on X: “Brief overview of venetoclax+azacitidine for elderly AML ineligible for intensive…

Dec 5, 2024, 15:08 | Drugs

Tranexamic acid among patients with haematological malignancies and severe thrombocytopenia - The Lancet Haematology

The Lancet Haematology shared on X: "NEW-Tranexamic acid did not prevent bleeding in patients with…

Oct 7, 2024, 09:03 | Blog

Syed Ali Abutalib: How I Treat patients with AML using azacitidine and venetoclax

Syed Ali Abutalib, Assistant Director, Cancer Treatment Centers of America, shared an article on X:…

Aug 18, 2024, 15:03 | Blog

Jorge Cortes: Olutasidenib among patients with R/R AML mIDH1 previously treated with venetoclax

Jorge Cortes, Director of the Georgia Cancer Center, shared on X about recent paper by…

Aug 14, 2024, 07:20 | Drugs

Keith W Pratz: Novel risk signature for AML treated with Azacitidine and Venetoclax

Keith W Pratz, Director of Leukemia at the Hospital of University of Pennsylvania, shared on…

All: 5 Posts: 1 - 100

'

April is Head and Neck Cancer Awareness Month

'

Is Cancer Hereditary? Myths and Facts about Cancer Genetics

'

Neuroendocrine Lung Tumors: Types, Symptoms, Diagnosis, Treatment and 2025 updates

'

Cancer Center Near Me: Dana-Farber Cancer Institute

'

FDA Approves Nivolumab and Ipilimumab for First-Line Treatment of Unresectable Hepatocellular Carcinoma Based on CheckMate-9DW Trial

Special Coverage

Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
ESMO 2024 Congress
September 13-17, 2024
ASCO Annual Meeting
May 30 - June 4, 2024
Yvonne Award 2024
May 31, 2024
OncoThon 2024, Online
Feb. 15, 2024
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023